Related Experiment Video

Updated: Jun 24, 2026

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor

Renee N Donahue1, Patricia J McLaughlin, Ian S Zagon

  • 1Department of Neural and Behavioral Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|March 20, 2009
PubMed

Insights

The opioid growth factor (OGF) and its receptor (OGFr) naturally regulate ovarian cancer cell growth. This OGF-OGFr pathway inhibits proliferation by affecting cyclin-dependent kinases, offering new therapeutic targets.

Area of Science:

  • Gynecological Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Ovarian cancer remains the leading cause of gynecological cancer mortality, with complex biology and treatment challenges.
  • The opioid growth factor (OGF) and OGF receptor (OGFr) constitute an endogenous pathway regulating cell growth in normal and cancerous tissues.

Purpose of the Study:

  • To investigate the presence, function, and mechanisms of the OGF-OGFr axis in human ovarian cancer.
  • To determine if the OGF-OGFr system plays a role in regulating ovarian cancer cell proliferation.

Main Methods:

  • Utilized ovarian cancer cell lines (OVCAR-3, SKOV-3, SW626, CAOV-3, HEY) to study OGF and OGFr.
  • Administered exogenous OGF and employed small interfering RNA (siRNA) to silence OGFr.
  • Investigated the mechanism of OGF action by examining the effects of p16 and p21 knockdown on DNA synthesis.

Main Results:

  • OGF and OGFr were found to be present and functional in ovarian cancer cell lines.
  • Exogenous OGF inhibited cell proliferation in a dose-dependent, reversible, and receptor-mediated manner, dependent on RNA and protein synthesis.
  • Endogenous OGF constitutively suppressed cell proliferation; its neutralization accelerated growth, and OGFr silencing stimulated replication.
  • OGF's inhibitory effect on DNA synthesis was linked to the cyclin-dependent kinase inhibitory pathway (p16/p21).

Conclusions:

  • The OGF-OGFr system is a native biological regulator of cell proliferation in human ovarian cancer.
  • This pathway's mechanism involves modulation of cyclin-dependent kinase inhibitors.
  • Findings provide a basis for developing novel therapeutic strategies targeting the OGF-OGFr axis for ovarian cancer treatment.

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays08:39

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays

Published on: January 3, 2015

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...